Purinergic ionotropic P2X7 receptors (P2X7Rs) are closely associated with excitotoxicity and nociception. Inhibition of P2X7R activation has been considered as a potentially useful strategy to improve recovery from spinal cord injury and reduce inflammatory damage to trauma. The physiological functions of P2X7Rs, however, are poorly understood, even though such information is essential for making the P2X7R an effective therapeutic target. We show here that P2X7Rs in satellite cells of dorsal root ganglia tonically inhibit the expression of P2X3Rs in neurons. Reducing P2X7R expression using siRNA or blocking P2X7R activity by antagonists elicits P2X3R up-regulation, increases the activity of sensory neurons responding to painful stimuli, and evokes abnormal nociceptive behaviors in rats. Thus, contrary to the notion that P2X7R activation is cytotoxic, P2X7Rs in satellite cells play a crucial role in maintaining proper P2X3R expression in dorsal root ganglia. Studying the mechanism underlying the P2X7R-P2X3R control, we demonstrate that activation of P2X7Rs evokes ATP release from satellite cells. ATP in turn stimulates P2Y1 receptors in neurons. P2Y1 receptor activation appears to be necessary and sufficient for the inhibitory control of P2X3R expression. We further determine the roles of the P2X7R-P2Y1-P2X3R inhibitory control under injurious conditions. Activation of the inhibitory control effectively prevents the development of allodynia and increases the potency of systemically administered P2X7R agonists in inflamed rats. Thus, direct blocking P2X7Rs, as proposed before, may not be the best strategy for reducing pain or lessening neuronal degeneration because it also disrupts the protective function of P2X7Rs.dorsal root ganglia ͉ neuron-glia communication ͉ P2Y1 ͉ pain ͉ inflammation P 2X3 receptors (P2X7Rs) and P2X7Rs receptors (P2X7Rs) are expressed in the spinal cord and dorsal root ganglia (DRGs) (1, 2) and are involved in neuron-glia communication (3, 4). P2X3Rs have been linked to nociceptive signaling (5-10) and become sensitized after inflammation or nerve injury (11-13). Most P2X7Rs are found in immune or glial cells, although limited neuronal expression of P2X7R has been documented (14-16). P2X7Rs play a prominent role in excitotoxicity and nociception (15)(16)(17)(18)(19). Activation of P2X7Rs has been associated with the maturation and release of proinflammatory cytokines from glial cells (20), which can cause an increase in neuronal excitability (4, 21) and exaggerated nociception (22,23). Spinal cord injury induces ATP release in the spinal cord and elicits apoptosis (15,24). Application of P2X7R antagonists to the spinal cord promotes cell survival and improves the locomotive behavioral score of injured rats (15). P2X7R knock-out mice fail to develop hyperalgesia or allodynic pain after inflammation, anti-collagen-induced arthritis, or nerve ligation (22,23). It is therefore suggested that blocking P2X7R activation is a valid strategy to treat spinal cord injuries and control chronic pain (15...